SHZ Equity Snapshot
002038 Weekly Equity Report
Beijing SL Pharmaceutical Co., Ltd.
What the company does
Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, research, development, and production of genetic engineering and related drugs People's Republic of China and internationally. The company's finished formulations include temozolomide; arsenic trioxide; lenalidomide capsules; pegylated human granulocyte-stimulating factor injection; human granulocyte-cell stimulating factor injection; recombinant human basic fibroblast growth factor for external use recombinant human basic fibroblast growth factor gel; human interleukin-11; arsenic trioxide; thymopentin; paclitaxel injection; docetaxel injection; vinorelbine tartrate injection; asparaginase; calcium folinate; gemcitabine hydrochloride; regorafenib tablets; oseltamivir phosphate capsules; ornidazole injection; adefovir dipivoxil capsules/adefovir dipivoxil tablets; ribavirin; valacyclovir hydrochloride; levofloxacin hydrochlorid; tenofovir …
What the weekly tape is saying
002038 closed the latest completed week at 5.37 CNY. The 4-week return is -12.1% and the 12-week return is -7.9%. Trend Signal is inactive, Market Dynamics is -0.61. Setup signature: Risk-first tape with a 10/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 7.00 CNY
- Vs Trend Line
- -23.3%
- Fair Value
- 7.91 CNY
- Vs Fair Value
- -32.1%
- 52W High
- 9.40 CNY
- 52W Low
- 5.28 CNY
- Drawdown
- -42.9%
- Range Position
- 2.2%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 21
- 52W Active Breadth
- 40.4%
- Sector Scope
- CN Healthcare
- Sector Rank
- 365 of 486
- Sector Percentile
- 24.9%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
CN Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -0.2%
- Avg 4W
- -7.7%
- Trend Breadth
- 15.0%
- Positive MD
- 24.0%
CN Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.0%
- Avg 4W
- -9.3%
- Trend Breadth
- 10.0%
- Positive RS
- 8.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.61
- 4W MD Change
- -346.6%
- Relative Strength
- -35.52
- 4W RS Change
- -10.0%
- Expectation
- Undecided
- Probability
- 50.21%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 96.4M
- 13W Average
- 298.2M
- 52W Average
- 163.2M
- Vs 13W
- 0.3x
- Vs 52W
- 0.6x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 12.3%
- 52W Volatility
- 7.3%
- Upside Weeks
- 24
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 4.7% / -4.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- SHZ
- Country
- CN
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- CNY
- Market Cap
- 5.9B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 5.37 CNY | -4.1% | 7.00 CNY | 7.91 CNY | -0.61 | -35.52 | 96.4M | Off |
| 5 Jun 2026 | 5.60 CNY | -4.8% | 7.07 CNY | 7.94 CNY | -0.44 | -35.04 | 101.4M | Off |
| 29 May 2026 | 5.88 CNY | -3.8% | 7.14 CNY | 7.96 CNY | -0.34 | -33.66 | 103.8M | Off |
| 22 May 2026 | 6.11 CNY | 0.0% | 7.19 CNY | 7.98 CNY | -0.26 | -31.83 | 119.4M | Off |
| 15 May 2026 | 6.11 CNY | -6.0% | 7.23 CNY | 8.00 CNY | -0.14 | -32.28 | 340.9M | Off |
| 8 May 2026 | 6.50 CNY | 0.2% | 7.27 CNY | 8.02 CNY | 0.10 | -28.58 | 107.0M | Off |
| 1 May 2026 | 6.49 CNY | -6.6% | 7.29 CNY | 8.03 CNY | 0.34 | -27.09 | 196.0M | Off |
| 24 Apr 2026 | 6.95 CNY | -8.6% | 7.31 CNY | 8.05 CNY | 0.66 | -21.64 | 342.1M | Off |
| 17 Apr 2026 | 7.60 CNY | 0.8% | 7.32 CNY | 8.06 CNY | 0.53 | -14.53 | 570.9M | Off |
| 10 Apr 2026 | 7.54 CNY | -16.0% | 7.32 CNY | 8.07 CNY | -0.07 | -12.19 | 706.3M | Off |
| 3 Apr 2026 | 8.98 CNY | 35.9% | 7.33 CNY | 8.07 CNY | -0.66 | 11.60 | 909.8M | Off |
| 27 Mar 2026 | 6.61 CNY | 13.4% | 7.28 CNY | 8.07 CNY | -1.26 | -20.20 | 208.6M | Off |
| 20 Mar 2026 | 5.83 CNY | -5.0% | 7.33 CNY | 8.08 CNY | -1.57 | -30.51 | 74.0M | Off |
| 13 Mar 2026 | 6.14 CNY | -1.9% | 7.41 CNY | 8.10 CNY | -1.57 | -29.42 | 67.9M | Off |